SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biogen reports Litifilimab safety profile consistent

Biogen Inc. announced that the safety profile of Litifilimab has been observed to be consistent, with no new safety signals identified.

BIIB

Related stories